Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Director's Dealing 2019

Jan 3, 2019

33003_dirs_2019-01-03_15c19b84-eed3-4748-98d8-f62ec133f3f4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2019-01-02

Reporting Person: Zarur Juan Andrey (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-01-02 Director Stock Option (Right to Buy) $28.92 A 10000 Acquired 2029-01-02 Common Stock (10000) Direct
2019-01-02 Director Stock Option (Right to Buy) $28.92 A 100000 Acquired 2029-01-02 Common Stock (100000) Direct

Footnotes

F1: This option was granted on January 2, 2019 and vests in full on the one year anniversary of the grant date.

F2: This option was granted on January 2, 2019 and vests in four equal consecutive annual installments beginning January 2, 2020.